PremiumThe FlyBiotech Alert: Searches spiking for these stocks today Biotech Alert: Searches spiking for these stocks today Longeveron’s Clinical Advancements and Strategic Positioning Earn a Buy Rating PremiumPre-EarningsLGVN Earnings this Week: How Will it Perform? Longeveron management to meet with Maxim Longeveron’s Lomecel receives WHO non-proprietary name approval as laromestroce PremiumThe FlyLongeveron appoints Blass as Chief Technology Officer Longeveron Inc. (LGVN) Q3 Earnings Cheat Sheet Longeveron presents Lomecel-B long-term transplant-free survival data in HLHS 
